{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:47:34Z","timestamp":1772120854918,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.humpath.2007.05.026","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T13:59:24Z","timestamp":1196949564000},"page":"194-200","source":"Crossref","is-referenced-by-count":25,"title":["T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?"],"prefix":"10.1016","volume":"39","author":[{"given":"Pierre","family":"Raynaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Caulet-Maugendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Foussard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Fran\u00e7ois","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Patey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Christine","family":"Rousselet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Christine","family":"Bene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Damotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Cornillet Lefebvre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Costes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2007.05.026_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/ajcp\/112.6.844","article-title":"Lymphoid aggregates in bone marrow mimic residual lymphoma after rituximab therapy for non Hodgkin lymphoma","volume":"112","author":"Douglas","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2007.05.026_bib2","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"12","author":"Van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2007.05.026_bib3","series-title":"World Health Organization classification of tumors: tumors of haematopoietic and lymphoid tissue","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.humpath.2007.05.026_bib4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20040119","article-title":"The innate mononuclear phagocyte net work depletes B lymphocytes through Fc receptor\u2013dependent mechanisms during anti CD20 antibody immunotherapy","volume":"199","author":"Uchida","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.humpath.2007.05.026_bib5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood.V98.5.1352","article-title":"Expression of complement inhibitors CD46, CD55 and CD59 on T cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma","volume":"98","author":"Weng","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.05.026_bib6","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood.V99.3.1038","article-title":"The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukaemia: evidence of caspase activation and apoptosis induction","volume":"99","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.05.026_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.2005.02720.x","article-title":"Rituxan (anti-CD20 antibody)\u2013induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis","volume":"139","author":"Janas","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humpath.2007.05.026_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood-2002-02-0469","article-title":"In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas","volume":"101","author":"Manches","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.05.026_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood.V97.1.101","article-title":"Rituximab (anti-CD20 monoclonal antibody) as single first line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation","volume":"97","author":"Colombat","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.05.026_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2141.2002.03843.x","article-title":"Incidence and nature of CD20-negative relapse following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective review","volume":"119","author":"Kennedy","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2007.05.026_bib11","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1080\/1042819021000040044","article-title":"Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study","volume":"43","author":"Chu","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2007.05.026_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1046\/j.1365-2141.2001.03019.x","article-title":"Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis","volume":"114","author":"Foran","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2007.05.026_bib13","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood.V92.9.3203","article-title":"Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase\u2013positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny","volume":"92","author":"Dworzak","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.05.026_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1023\/A:1008416911099","article-title":"Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low grade or follicular non-Hodgkin's lymphoma","volume":"9","author":"Berinstein","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2007.05.026_bib15","first-page":"1","article-title":"CD20: a review","volume":"4","author":"Chang","year":"1999","journal-title":"Appl Immunochem"},{"key":"10.1016\/j.humpath.2007.05.026_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1023\/A:1015463811683","article-title":"Cross-priming of cytotoxic T cells promoted by apoptosis-inducing tumor cell reactive antibodies?","volume":"22","author":"Selenko","year":"2002","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.humpath.2007.05.026_bib17","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood-2004-03-1110","article-title":"From the bench to the bedside: ways to improve rituximab efficacy","volume":"104","author":"Cartron","year":"2004","journal-title":"Blood"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707003048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707003048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T02:22:35Z","timestamp":1588126955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817707003048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0046817707003048"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2007.05.026","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1120241.576404","asserted-by":"object"}]},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}